Genetic biomarkers of placebo response: what could it mean for future trial design?
Program in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA ; Division of General Medicine & Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Kathryn T
KT
Hall
Ted J
TJ
Kaptchuk
COMT; Val158Met; biomarkers; doctor–patient; enrichment strategies; placebo effect; randomized controlled trial